advertisement
Retina (Philadelphia, Pa.) 32
Showing records 1 to 25 | Display all abstracts in Retina (Philadelphia, Pa.)70281 INFECTIOUS ENDOPHTHALMITIS AFTER GLAUCOMA DRAINAGE IMPLANT SURGERY: Clinical Features, Microbial Spectrum, and Outcomes
Zheng CX
Retina (Philadelphia, Pa.) 2017; 37: 1160-1167
70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Chin EK
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351
70702 REPRODUCIBILITY OF VESSEL DENSITY MEASUREMENT WITH OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN EYES WITH AND WITHOUT RETINOPATHY
You Q
Retina (Philadelphia, Pa.) 2017; 37: 1475-1482
70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Malclès A
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359
70515 DIFFERENT SURGICAL MODALITIES FOR MANAGEMENT OF PERSISTENT GLAUCOMA AFTER SILICONE OIL REMOVAL IN VITRECTOMIZED EYES: One Year Comparative Study
El-Saied HM
Retina (Philadelphia, Pa.) 2017; 37: 1535-1543
70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Dot C
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359
70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Almeida DR
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351
70515 DIFFERENT SURGICAL MODALITIES FOR MANAGEMENT OF PERSISTENT GLAUCOMA AFTER SILICONE OIL REMOVAL IN VITRECTOMIZED EYES: One Year Comparative Study
Abdelhakim MA
Retina (Philadelphia, Pa.) 2017; 37: 1535-1543
70702 REPRODUCIBILITY OF VESSEL DENSITY MEASUREMENT WITH OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN EYES WITH AND WITHOUT RETINOPATHY
Freeman WR
Retina (Philadelphia, Pa.) 2017; 37: 1475-1482
70281 INFECTIOUS ENDOPHTHALMITIS AFTER GLAUCOMA DRAINAGE IMPLANT SURGERY: Clinical Features, Microbial Spectrum, and Outcomes
Moster MR; Khan MA
Retina (Philadelphia, Pa.) 2017; 37: 1160-1167
70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Velez G
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351
70702 REPRODUCIBILITY OF VESSEL DENSITY MEASUREMENT WITH OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN EYES WITH AND WITHOUT RETINOPATHY
Weinreb RN
Retina (Philadelphia, Pa.) 2017; 37: 1475-1482
70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Voirin N
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359
70281 INFECTIOUS ENDOPHTHALMITIS AFTER GLAUCOMA DRAINAGE IMPLANT SURGERY: Clinical Features, Microbial Spectrum, and Outcomes
Chiang A
Retina (Philadelphia, Pa.) 2017; 37: 1160-1167
70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Vié AL
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359
70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Xu K
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351
70702 REPRODUCIBILITY OF VESSEL DENSITY MEASUREMENT WITH OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN EYES WITH AND WITHOUT RETINOPATHY
Zangwill L
Retina (Philadelphia, Pa.) 2017; 37: 1475-1482
70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Agard É
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359
70702 REPRODUCIBILITY OF VESSEL DENSITY MEASUREMENT WITH OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN EYES WITH AND WITHOUT RETINOPATHY
Manalastas PI
Retina (Philadelphia, Pa.) 2017; 37: 1475-1482
70281 INFECTIOUS ENDOPHTHALMITIS AFTER GLAUCOMA DRAINAGE IMPLANT SURGERY: Clinical Features, Microbial Spectrum, and Outcomes
Garg SJ
Retina (Philadelphia, Pa.) 2017; 37: 1160-1167
70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Peraire M
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351
70702 REPRODUCIBILITY OF VESSEL DENSITY MEASUREMENT WITH OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN EYES WITH AND WITHOUT RETINOPATHY
Saunders LJ
Retina (Philadelphia, Pa.) 2017; 37: 1475-1482
70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Corbella M
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351
70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Bellocq D
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359
70281 INFECTIOUS ENDOPHTHALMITIS AFTER GLAUCOMA DRAINAGE IMPLANT SURGERY: Clinical Features, Microbial Spectrum, and Outcomes
Dai Y
Retina (Philadelphia, Pa.) 2017; 37: 1160-1167